Concentrations	3 Months Ended
Mar. 31, 2025
Risks and Uncertainties [Abstract]
Concentrations	Note 7 – Concentrations The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of its cash and accounts receivable. The Company maintains its cash balances in bank deposit and money market accounts which, at times, may exceed federally insured limits. Sales and Accounts Receivable During the periods ended March 31,2025 and 2024, three (3) receivable customers that totaled 82% of sales, respectively, and $100,000 accounts payable. During the years ended December 31, 2024, one (1) franchise totaled 41% of sales, and one (1) customer totaled 63% accounts receivable, respectively. The Company performs ongoing credit valuations of its customers and management believes that the financial viability of these customers is sound. Purchases and Payables There was no concentration of purchases or payables for the Company for the three months ended March 31, 2025, and the year ended December 31, 2024.

Concentrations

3 Months Ended

Mar. 31, 2025

Note 7 – Concentrations

The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of its cash and accounts receivable. The Company maintains its cash balances in bank deposit and money market accounts which, at times, may exceed federally insured limits.

Sales and Accounts Receivable

During the periods ended March 31,2025 and 2024, three (3) receivable customers that totaled 82% of sales, respectively, and $100,000 accounts payable.

During the years ended December 31, 2024, one (1) franchise totaled 41% of sales, and one (1) customer totaled 63% accounts receivable, respectively.

The Company performs ongoing credit valuations of its customers and management believes that the financial viability of these customers is sound.

Purchases and Payables

There was no concentration of purchases or payables for the Company for the three months ended March 31, 2025, and the year ended December 31, 2024.